Identification of the JAK2 V617F mutation is a major diagnostic criterion for the classical myeloproliferative neoplasms (MPN) of polycythemia vera, essential thrombocythemia and primary myelofibrosis. Here, JAK2 is linked to myeloproliferative neoplasm.